Company profile for Molteni Farmaceutici

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

L. Molteni & C., is a privately-owned Italian pharmaceutical company, founded in 1892, with main activities in development, production and marketing of mainly narcotic finished pharmaceutical products in different formulation, oral liquid/injectable glass and plastic ampoules, plastic bags for infusion in Pain, Addiction & General Anaesthesia therapeutic areas.Our HQ and manufacturing site is in Florence. Molteni is continuous...
L. Molteni & C., is a privately-owned Italian pharmaceutical company, founded in 1892, with main activities in development, production and marketing of mainly narcotic finished pharmaceutical products in different formulation, oral liquid/injectable glass and plastic ampoules, plastic bags for infusion in Pain, Addiction & General Anaesthesia therapeutic areas.Our HQ and manufacturing site is in Florence. Molteni is continuously growing internationally, outside Italy, we are directly present in Poland since 1994, while in many other European and non-European countries, through qualified distributors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Italy
Address
Address
Via Ilio Barontini, 8, 50018 Scandicci FI
Telephone
Telephone
39 349 515 8678
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmacompass.com/pdf/news/molteni-enters-into-european-distribution-agreement-with-accord-healthcare-1600679467.pdf

PRESS RELEASE
15 Sep 2020

https://www.prnewswire.com/news-releases/accord-healthcare-conclut-un-accord-de-distribution-exclusif-avec-molteni-farmaceutici-pour-le-premier-implant-de-buprenorphine-approuve-en-europe-873791168.html

PRNEWSWIRE
13 Sep 2020

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty